Open AccessEVALUATION OF DRUG THERAPY IN PROGRESSING DIFFERENTIATED THYROID CANCER REFRACTORY TO RADIOACTIVE IODINE IN PATIENTS RESIDING IN THE RUSSIAN FEDERATION : PHARMACOECONOMIC ASPECTS
Author(s) -
M. Yu. Frolov,
В. А. Рогов
Publication year - 2017
Publication title -
farmakoèkonomika
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.177
H-Index - 3
eISSN - 2070-4933
pISSN - 2070-4909
DOI - 10.17749/2070-4909.2017.10.1.003-010
Subject(s) - lenvatinib , sorafenib , medicine , thyroid cancer , refractory (planetary science) , oncology , drug , cancer , pharmacology , hepatocellular carcinoma , physics , astrobiology